Nomura Holdings Inc Sarepta Therapeutics, Inc. Put Options Transaction History

Nomura Holdings Inc

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1.7 Million - $2.46 Million	15,000 New	15,000 $2.37 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $16 Million - $19.1 Million	-336,500 Reduced 37.96%	550,000 $30.7 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $31.7 Million - $41.8 Million	886,500	886,500 $40.2 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.